← Evidence map

ArticleJCI insight2022

DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma.

Thale Kristin Olsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

28 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35943801